Nothing Special   »   [go: up one dir, main page]

AU3501697A - Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration - Google Patents

Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration

Info

Publication number
AU3501697A
AU3501697A AU35016/97A AU3501697A AU3501697A AU 3501697 A AU3501697 A AU 3501697A AU 35016/97 A AU35016/97 A AU 35016/97A AU 3501697 A AU3501697 A AU 3501697A AU 3501697 A AU3501697 A AU 3501697A
Authority
AU
Australia
Prior art keywords
postischemic
topiramate
neurodegeneration
medicament
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35016/97A
Inventor
Bruce E. Maryanoff
Richard P. Shank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU3501697A publication Critical patent/AU3501697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35016/97A 1996-06-28 1997-06-24 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration Abandoned AU3501697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2200396P 1996-06-28 1996-06-28
US60022003 1996-06-28
PCT/US1997/010977 WO1998000124A1 (en) 1996-06-28 1997-06-24 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration

Publications (1)

Publication Number Publication Date
AU3501697A true AU3501697A (en) 1998-01-21

Family

ID=21807331

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35016/97A Abandoned AU3501697A (en) 1996-06-28 1997-06-24 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration

Country Status (3)

Country Link
AU (1) AU3501697A (en)
WO (1) WO1998000124A1 (en)
ZA (1) ZA975769B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01010217A (en) 1999-04-08 2005-09-08 Johnson & Johnson Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders.
AU775296B2 (en) 1999-07-26 2004-07-29 Ortho-Mcneil Pharmaceutical, Inc. Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
CA2437333A1 (en) 2001-02-02 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
JP2004331502A (en) * 2001-06-18 2004-11-25 Ortho Mcneil Pharmaceut Inc Optical nerve cell protecting agent
WO2003020289A1 (en) * 2001-08-30 2003-03-13 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (en) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. Process for preparation of sulfamide derivatives
AR058389A1 (en) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8853263B2 (en) 2006-05-19 2014-10-07 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders
BRPI0915890A2 (en) 2008-06-23 2015-11-03 Janssen Pharmaceutica Nv (2s) - (-) - n- (6-chloro-2,3-dihydro-benzo [1,4] dioxin-2-ylmethyl) sulfamide crystalline form
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives

Also Published As

Publication number Publication date
ZA975769B (en) 1998-12-28
WO1998000124A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU3560495A (en) Medicament inhaler
AU3739397A (en) Catheter guidewire
AU3994597A (en) Neovascularization catheter
AU2455697A (en) Triple lumen catheter
AU1735495A (en) Microballoon catheter
AU1139695A (en) Esophageal-tracheal double lumen airway
AU6857796A (en) X-ray catheter
AU686518B2 (en) Bi-directional catheter
AU5845398A (en) Steerable catheter
AU7381094A (en) Triple lumen catheter
AU5582896A (en) Balloons for medical catheters
EP0879013A4 (en) Medical guidewire
AU3641295A (en) Anastomosis catheter
AU4830099A (en) Ep catheter
AU2605295A (en) Balloon catheter
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
HUP0003381A3 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
AU3501697A (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
AU4980196A (en) Balloon catheter
AU2208700A (en) Infant inhaler
AU5801996A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
AU2523795A (en) Inhaler
AU2547597A (en) Double lumen catheter
EP0747346A3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
AU1142600A (en) Catheter